Watchlist Price Alert

Citius Pharmaceuticals In... (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

0.77

0.05 (6.65%)

At close: May 02, 2025, 3:58 PM

0.77

-0.05%

After-hours: May 02, 2025, 04:05 PM EDT

Citius Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015
Net Income	-10.28M	-11.08M	-10.57M	-8.54M	-9.23M	-9.94M	-8.48M	-10.53M	-3.59M	-7.99M	-8.86M	-7.56M	-9.23M	-4.96M	-5.82M	-4.12M	-8.15M	-4.12M	-4.68M	-4.42M	-4.32M	-3.65M	-4.41M	-3.63M	-3.87M	-2.85M	-2.02M	-4.42M	-3.25M	-3.04M	-2.42M	-2.74M	-2.18M	-2.59M	-3.62M	-869.45K	-1.22M
Depreciation & Amortization	54.84K	53.69K	52.85K	52.07K	51.01K	49.97K	49.02K	48.14K	47.19K	46.25K	45.35K	44.47K	43.61K	42.77K	41.68K	40.59K	39.82K	39.13K	31.04K	47.45K	34.75K	187.00	236.00	235.00	235.00	235.00	235.00	641.00	642.00	617.00	672.00	671.00	672.00	672.00	671.00	n/a	n/a
Stock-Based Compensation	2.52M	2.64M	3.06M	3.08M	3.06M	3.08M	1.17M	1.17M	1.2M	976.67K	1M	1.02M	904.6K	461.87K	373.57K	342.96K	276.58K	249.03K	175.01K	158.83K	220.38K	137.04K	204K	203.69K	171.25K	150.62K	124.4K	214.67K	290.02K	178.26K	266.81K	300.03K	241.51K	214.47K	280.76K	115.61K	121.3K
Other Working Capital	6.39M	-938.42K	-156.42K	-2.64M	46.62K	26.14K	-2.82M	25.28K	-3M	480.13K	117.18K	-3.26M	3.02M	-890.45K	363.46K	-749.12K	-862.02K	330.06K	173.06K	-532.05K	19.26K	228.62K	174.22K	-381.75K	1.03M	-469.62K	108.34K	-398.18K	298.29K	-90.74K	-913.83K	262.42K	1.16M	769K	-661.11K	-71.69K	526.74K
Other Non-Cash Items	n/a	1.00	109.95K	3.26M	76.15K	3.33M	918.07K	102K	923.25K	104.32K	1.11M	178K	95.88K	-166.56K	235.15K	68K	-872.06K	100K	22.75K	306.02K	100K	94.1K	504.78K	117.5K	509.99K	661.11K	31K	-361.2K	257.4K	901.45K	551.76K	478.57K	-622.19K	-761.52K	1.49M	287.85K	-23.94K
Deferred Income Tax	264.24K	144K	144K	144K	144K	144K	144K	144K	144K	576K	-1.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-450K	n/a	n/a	133.51K	n/a	n/a	-821.52K	n/a	n/a	n/a
Change in Working Capital	2.71M	2.33M	-1.16M	-2.61M	-233.46K	-126.19K	-2.47M	1.21M	-2.62M	-45.01K	102.57K	-3.35M	3.53M	-968.02K	585.25K	-600.42K	-1.73M	374.68K	460.32K	-554.95K	-1.15M	511.3K	679K	-539.09K	1.54M	191.49K	-379.8K	441.13K	257.02K	-1.47M	-799.25K	1.14M	1.24M	1.37M	-718.63K	-408.46K	426.28K
Operating Cash Flow	-4.73M	-5.91M	-8.37M	-7.79M	-6.14M	-6.8M	-9.58M	-7.85M	-4.82M	-6.33M	-7.71M	-9.67M	-4.65M	-5.59M	-4.82M	-4.27M	-9.56M	-3.36M	-3.99M	-4.47M	-5.11M	-2.91M	-3.52M	-3.85M	-2.16M	-2.5M	-2.25M	-4.13M	-2.44M	-3.43M	-2.4M	-824.6K	-1.31M	-1.77M	-2.56M	-874.45K	-697.09K
Capital Expenditures	n/a	n/a	-4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-40M	-6.94K	n/a	n/a	n/a	-1.83K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.13K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	255.75K	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-40M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	255.75K	n/a	n/a	n/a
Investing Cash Flow	n/a	-5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-40M	-6.94K	n/a	n/a	n/a	-1.83K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.13K	n/a	n/a	n/a	255.75K	n/a	255.75K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	300K	2.56M	530K	820K	500K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-3.83M	13.72M	n/a	n/a	-687	13.8M	31.27K	n/a	n/a	n/a	n/a	n/a	-31.04M	16.8M	14.24M	n/a	n/a	1.29M	6.03M	106.00	n/a	n/a	7.22K	16K	n/a	n/a	n/a	1.13M	6.14M	-19.96K	n/a	n/a	-64.8K	-600K	n/a	n/a
Financial Cash Flow	2.57M	-3.75M	13.72M	n/a	n/a	-687	13.8M	31.27K	n/a	n/a	n/a	n/a	n/a	-120.47M	16.8M	103.67M	500.00	8.7M	8.17M	6.03M	106.00	6.29M	4.83M	7.22K	16K	8.93M	n/a	1.76M	6.61M	6.44M	2.54M	838.95K	1.07M	435.2K	429K	4.1M	302.44K
Net Cash Flow	-2.15M	-14.66M	5.35M	-7.79M	-6.14M	-6.8M	4.22M	-7.82M	-4.82M	-6.33M	-7.71M	-9.67M	-4.65M	-45.59M	11.97M	99.4M	-9.56M	5.34M	4.18M	1.56M	-5.11M	3.38M	1.31M	-3.84M	-2.14M	6.42M	-2.25M	-2.36M	4.17M	3.01M	137.62K	14.35K	-247.59K	-1.33M	-2.13M	3.48M	-394.65K
Free Cash Flow	-4.73M	-5.91M	-8.37M	-7.79M	-6.14M	-6.8M	-9.58M	-7.85M	-4.82M	-6.33M	-7.71M	-9.67M	-4.65M	-45.59M	-4.83M	-4.27M	-9.56M	-3.36M	-3.99M	-4.47M	-5.11M	-2.91M	-3.52M	-3.85M	-2.16M	-2.5M	-2.25M	-4.13M	-2.44M	-3.43M	-2.4M	-824.6K	-1.31M	-1.77M	-2.56M	-874.45K	-697.09K